Private Capital Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,287
Closed -$296K 2132
2021
Q4
$296K Buy
2,287
+27
+1% +$3.15K 0.06% 182
2021
Q3
$256K Sell
2,260
-32
-1% -$3.65K 0.06% 196
2021
Q2
$237K Sell
2,292
-19
-0.8% -$1.79K 0.05% 207
2021
Q1
$193K Sell
2,311
-113
-5% -$9.55K 0.05% 231
2020
Q4
$221K Buy
2,424
+1,219
+101% +$101K 0.04% 291
2020
Q3
$96K Sell
1,205
-115
-9% -$8.97K 0.02% 460
2020
Q2
$91K Sell
1,320
-24
-2% -$1.71K 0.02% 474
2020
Q1
$85K Buy
1,344
+897
+201% +$64.7K 0.02% 448
2019
Q4
$34K Sell
447
-342
-43% -$26.7K 0.01% 895
2019
Q3
$58K Sell
789
-1,536
-66% -$108K 0.01% 702
2019
Q2
$113K Buy
2,325
+390
+20% +$23.6K 0.03% 354
2019
Q1
$123K Sell
1,935
-204
-10% -$11.6K 0.02% 397
2018
Q4
$109K Buy
2,139
+18
+0.8% +$911 0.02% 360
2018
Q3
$123K Sell
2,121
-204
-9% -$9.98K 0.02% 366
2018
Q2
$112K Buy
+2,325
New +$109K 0.02% 385

Other funds holding EW

Private Capital Group's EW Position: Q1 2022 in Review

Private Capital Group sold out of Edwards Lifesciences (EW) in Q1 2022, closing a stake of 2,287 shares — an estimated $296K sold.

Private Capital Group first reported a position in EW in Q2 2018 and held it in 15 quarters. The position peaked at $296K in Q4 2021. 1,315 funds tracked by Wall St. Rank hold EW as of Q1 2022.

  • Private Capital Group reported no remaining Edwards Lifesciences position as of Q1 2022 after selling out during the quarter.
  • Private Capital Group sold 2,287 Edwards Lifesciences shares in Q1 2022, an estimated $296K.
  • Private Capital Group first reported a position in Edwards Lifesciences in Q2 2018 and held it in 15 quarters.
  • Private Capital Group's Edwards Lifesciences position peaked at $296K in Q4 2021.
  • 1,315 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2022.

Based on Private Capital Group's 13F filing for Q1 2022, filed 21 Apr 2022.